CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation — NEJM

Retweeted NEJM (@NEJM): Oral CMX001 2x/week reduces incidence of CMV events in recipients of hematopoietic-cell transplants. http://t.co/2zdh8oaU43

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/2zdh8oaU43